Development of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies

Overview of attention for article published in Frontiers in immunology, May 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 23 news outlets
twitter: 7 X users

patent: 12 patents

Citations

dimensions_citation: 40 Dimensions

Readers on

mendeley: 66 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 12 patents that reference this research output.

HIGH AFFINITY IL-2 RECEPTOR AGONISTS AND IMMUNOSUPPRESSANTS TO ENHANCE IMMUNE TOLERANCE

Application WO-2023196566-A1

World Intellectual Property Organisation (WIPO)

Tolerogenic synthetic nanocarriers for allergy therapy

Grant US-11779641-B2

United States of America

SYNTHETIC NANOCARRIERS COMPRISING AN IMMUNOSUPPRESSANT IN COMBINATION WITH HIGH AFFINITY…

Application WO-2023183568-A1

World Intellectual Property Organisation (WIPO)

IMMUNOSUPPRESSANT IN COMBINATION WITH HIGH AFFINITY IL-2 RECEPTOR AGONISTS AND RELATED…

Application WO-2023172628-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 8 additional patents.